UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 92 filers reported holding UTAH MED PRODS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| METROPOLITAN LIFE INSURANCE CO/NY | 249 | $21,414 | 0.00% |
| MetLife Investment Management, LLC | 2,030 | $174,580 | 0.00% |
| Bank of New York Mellon Corp | 31,399 | $2,700,292 | 0.00% |
| Man Group plc | 4,578 | $393,708 | 0.00% |
| GOLDMAN SACHS GROUP INC | 40,956 | $3,522,216 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 2,643 | $227,298 | 0.00% |
| MERCER GLOBAL ADVISORS INC /ADV | 4,398 | $378 | 0.00% |
| JPMORGAN CHASE & CO | 58,266 | $5,010,876 | 0.00% |
| QUADRANT CAPITAL GROUP LLC | 128 | $11,008 | 0.00% |
| Ameritas Investment Partners, Inc. | 296 | $25,456 | 0.00% |
| Copeland Capital Management, LLC | 338 | $29,068 | 0.00% |
| NORTHERN TRUST CORP | 37,166 | $3,196,276 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 3,133 | $269,438 | 0.00% |
| Allspring Global Investments Holdings, LLC | 610 | $52,460 | 0.00% |
| Covestor Ltd | 4 | $0 | 0.00% |
| BARCLAYS PLC | 655 | $57 | 0.00% |
| ROYAL BANK OF CANADA | 1,675 | $144,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 4,716 | $405,576 | 0.00% |
| VANGUARD GROUP INC | 168,158 | $14,461,588 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 1,934 | $166,324 | 0.00% |
External links
This page lists UTAH MED PRODS INC's shareholders in Q3 2023. To view UTAH MED PRODS INC's shareholder history, click here.